The World Health Organization has authorized a second dengue vaccine, a move that could provide protection for millions ...

Cases of dengue - which is transmitted through bites by infected mosquitos - are expected to rise globally due to climate ...

The World Health Organisation (WHO) has prequalified a second vaccine for dengue, made by the Japanese drug maker Takeda ...

The World Health Organization has authorized a second dengue vaccine, manufactured by Takeda, for children aged six to 16 living in regions with high rates.

The newly prequalified vaccine, TAK-003 is developed by a multinational pharmaceutical company, Takeda as the second dengue ...

Takeda’s vaccine, given in two doses over a three-month interval, protects against four serotypes of the dengue virus. It was ...

Dengue, a mosquito-borne disease, poses a significant health threat with an estimated 100 to 400 million cases annually. The disease is prevalent in Asia, Africa and the Americas, with the WHO region ...

Press Release - A new vaccine for dengue received prequalification from the World Health Organization (WHO) on 10 May 2024. TAK-003 is the second dengue vaccine to be prequalified by WHO. Developed by ...

Following is a summary of current health news briefs. No shortage of Wegovy weight-loss drug in Denmark, Novo Nordisk says ...

The World Health Organization (WHO) has prequalified a new dengue vaccine known as TAK-003. Developed by Takeda, this ...

The World Health Organization gives green light to new dengue vaccine - The move could provide protection for millions ...